Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andrew Arno currently holds 17,481 shares of Oncocyte Corp (OCX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew Arno has been a net buyer of OCX stock. They have purchased $678.7K and sold $0 worth of shares.
Andrew Arno's most recent insider trade was on Nov 10, 2025, when they sold 17,295 shares at $0.00 per share.
Andrew Arno serves as Executive at Oncocyte Corp (OCX). They have executed 50 insider transactions totaling $678.7K over their tenure at the company.
Andrew Arno holds the position of Executive at Oncocyte Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 15 years and currently hold a stake valued at $0.
Andrew Arno has shown a buying trading pattern, with $678.7K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Andrew Arno was on Aug 16, 2022, when they purchased $112.1K worth of OCX shares. This transaction involved 115,523 shares at $0.97 per share.
Andrew Arno currently owns 17,481 shares of Oncocyte Corp (OCX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andrew Arno's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andrew Arno has 50 Form 4 filings on record as an insider at Oncocyte Corp.
Set alerts for Andrew Arno and 40,000+ other insiders.